Reference Database & Longitudinal Registry of the Normal and Pathological Aging Brain

NCT ID: NCT02875496

Last Updated: 2019-11-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-08-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Establishment of a BNA reference database for the Adult and Elderly Population. Hypothesis-generating study designed to collect data that will aid in future scientific and engineering exploration of correlations between clinical assessments and BNA scores. The results are primarily intended for scientific inquiry and engineering development purposes, and may be used in future regulatory submissions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Currently, there is no reliable, bedside, and non-invasive method for assessing connectivity changes in electrophysiological activity of the brain associated with brain-related pathologies, e.g., concussion, ADHD, autistic spectrum disorders (ASD), etc. Event Related Potentials (ERPs), which are temporal reflections of the neural mass electrical activity of cells in specific regions of the brain that occur in response to stimuli, may offer such a method, as they provide both a non-invasive and portable measure of brain function. The ERPs provide excellent temporal information, but spatial resolution for ERPs has traditionally been limited. However, by using high-density electroencephalograph (EEG) recording, spatial resolution for ERPs is improved significantly. The paradigm for the current study will combine neurophysiological knowledge with mathematical signal processing and pattern recognition methods (BNA) to temporally and spatially map brain function, connectivity and synchronization.

The need of objective measures that will help the clinician in its decision-making in brain-related pathologies is recognized. BNA is a new imaging modality that has been developed to fill this gap.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Onset Alzheimer Disease Mild Cognitive Impairment Depression Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy aging

Subjects meeting criteria for healthy aging No intervention administered

No interventions assigned to this group

Early Alzheimer Disease

Subjects meeting criteria for Early Alzheimer Disease No intervention administered

No interventions assigned to this group

Depression

Subjects meeting criteria for Depression No intervention administered

No interventions assigned to this group

MCI-Mild Cognitive Impairment

Subjects meeting criteria for MCI-Mild Cognitive Impairment No intervention administered

No interventions assigned to this group

General Arm

Subjects not meeting criteria for any of the other arms (Healthy, Early Alzheimer's, Depression, or MCI)

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently resides in The Villages community
* Age 50-years and above.
* Able to speak, read and understand English
* Willingness to participate and able to give informed consent.
* If corrected vision: only Glasses should be used during the study testing


* BDI score \<14
* Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR,
* MMSE score ≥25


* BDI score \<14
* Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR, as determined by clinical evaluation by a research clinician and the Mini International Neuropsychiatric Interview (MINI).
* MMSE score \<24
* MoCA\<20
* Presence of an early and significant episodic memory impairment


* BDI score \>14
* Subjects meeting full diagnostic criteria for MDD without psychotic features per the DSM IV-TR
* HAM-D 17-item: Total score of 16 or higher at visit 1.


* BDI score \<14
* Subjects Not meeting diagnostic criteria for MDD per the DSM IV-TR
* MMSE scores according to Number of years of Education:

MMSE score Years of Education 17-18 ≤6 20-21 7-8 23-24 ≥10

-20\<MoCA score \>26

Exclusion Criteria

* Currently with lice or open wounds on scalp.
* Any CNS neurologic disorder
* Significant sensory deficits.
* Use of a hearing aid that occupies the ear canal
* Any neuropsychological disorders
* History of special education
* Substance abuse in the last 3 months
* History of any clinically significant brain trauma as determined by the investigator.
* Clinically diagnosed with a concussion in the past year.

For Arm 1 Healthy


* Any chronic disease or condition which affects the nervous system as determined by clinical neurological evaluation, medical history or PI discretion.
* Any psychiatric disorder,
* History of any medication affecting CNS within the last 3 months

For Arm 2 Early Alzheimer's Disease


* Any chronic disease or condition other than current pathology
* Any other psychiatric disorder
* CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.

For Arm 3 Depression


* Any chronic disease or condition other than current pathology
* Any psychiatric disorder other than Depression
* CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.

For Arm 4 Mild Cognitive Impairment


* Any chronic disease or condition other than current pathology
* Any other psychiatric disorder
* CNS medications within the short period of time prior to the EEG testing which are not in a medically stable treatment phase.
Minimum Eligible Age

50 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ElMindA Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeffrey Lowenkron, MD

Role: PRINCIPAL_INVESTIGATOR

Chief Medical Officer, The Villages Health

Carla VandeWeerd, PhD

Role: PRINCIPAL_INVESTIGATOR

Director of Research, The Villages Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Villages Health

The Villages, Florida, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carla VandeWeerd, PhD

Role: CONTACT

352-674-8859

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carla VanderWeerd, PhD

Role: primary

352-674-8859

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ELM-26

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

North American Prodromal Synucleinopathy Consortium
NCT03623672 ENROLLING_BY_INVITATION
BDNF and Motor Learning
NCT02074696 TERMINATED